There have been two reports that brain insulin markers are associated with CSF tau burden [242, 274], and seemingly no reports that the brain insulin measures are associated with amyloid burden specifically (except for the aforementioned tau-to-amyloid ratio data in [273]). The gene discussed is MAPT; the disease is amyloidosis.